Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Pharma
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Following an activist investor feud earlier this year, vaccine developer Dynavax Technologies has agreed to sell itself to France’s Sanofi.
Fraiser Kansteiner
Dec 29, 2025 10:24am
Does the Q4 M&A binge foreshadow a boom year for deals in 2026?
Dec 24, 2025 5:00am
NanoVibronix rebrand feeds into new focus on ENvue system
Dec 12, 2025 11:00am
Omnicom Health names IPG Health’s Dana Maiman CEO
Dec 1, 2025 11:09am
Lundbeck looks to buy Avadel from under Alkermes with $2.25B bid
Nov 14, 2025 9:29am
Fierce Biotech
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
